Trial Profile
Phase2 study of itraconazole,abraxane, carboplatin and avastin for advanced nonsquamous nonsmall cell lung cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary) ; Carboplatin; Itraconazole
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 06 Oct 2015 New trial record